Synlogic reports Q1 net loss of $15.7M; cash $120.5M supports runway into 2024

SYNLOGIC, INC.

2023-Q1 EPS reported -$0.22 revenue$244,000

Net loss of $15.7M ($0.22/share) vs $15.0M ($0.36/share) in Q1 2021.
Revenue of $0.2M from Roche collaboration; no revenue in Q1 2021.
Cash, cash equivalents and short-term investments $120.5M; expected funding into 2024.
PKU program progressing to Phase 3 readiness; expects Phase 2 data and candidate selection in H2 2022.
Michael Jensen appointed CFO in March 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.